Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nutrition (Burbank, Los Angeles County, Calif.)|July 30, 2008
Antibodies as pharmacologic tools for studies on the regulation of energy balanceKarl G Hofbauer, Anne-Catherine Lecourt, Jean-Christophe Peter
Journal of Receptor and Signal Transduction Research|November 25, 2010
Antibodies raised against different extracellular loops of the melanocortin-3 receptor affect energy balance and autonomic function in ratsJean-Christophe Peter, Géraldine Zipfel, Anne-Catherine Lecourt, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 27, 2007
Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivoJean-Christophe Peter, Janet R Nicholson, Déborah Heydet, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 2, 2010
A pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administrationJean-Christophe Peter, Anne-Catherine Lecourt, Marjorie Weckering, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 23, 2012
Protective effects of an anti-melanocortin-4 receptor scFv derivative in lipopolysaccharide-induced cachexia in ratsJean-Christophe Peter, Hélène Rossez, Marjorie Weckering, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
Anti-melanocortin-4 receptor autoantibodies in obesityJean-Christophe Peter, Akkiz Bekel, Anne-Catherine Lecourt, et al.
Rheumatology (Oxford, England)|September 29, 2018
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosusAnne-Katrin Pröbstel, Madlaina Thanei, Barbara Erni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 17, 2025
Patient-Derived Monoclonal Myelin Oligodendrocyte Glycoprotein Autoantibodies Mediate CytotoxicityNora Sandrine Wetzel, Laila Kulsvehagen, Anne-Catherine Lecourt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 20, 2024
Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated DiseaseAna Beatriz Ayroza Galvão Ribeiro Gomes, Su-Hyun Kim, Roxanne Pretzsch, et al.
Pageof 2